PRESS RELEASES

 

EPIVAX THERAPEUTICS APPOINTS NICOLE RUGGIERO AS CHIEF EXECUTIVE OFFICER AND GUILHEM RICHARD AS CHIEF TECHNOLOGY OFFICER

March 29, 2022

EpiVax Therapeutics is excited to announce the appointment of Nicole Ruggiero as Chief Executive Officer and Guilhem Richard as Chief Technology Officer.